We have competing offers from a private equity sponsor looking for a platform and a strategic buyer looking for market share, but their valuation structures are completely different. How do we weigh a higher strategic valuation with a complex earnout against a lower financial sponsor offer with rollover equity?

Question

Tyler Smith · Accepted Answer

This is a classic dilemma that requires you to look beyond the headline purchase price. A strategic buyer is buying synergies, which is why they often offer a higher multiple. However, they almost always want to fully integrate your company into theirs, which can dilute your culture and usually comes with a heavy, complex earnout tied to post-close performance.

A financial sponsor, like a private equity firm, is buying your operational platform. They typically offer a lower initial multiple but require you to roll over fifteen to thirty percent of your equity into their new holding company. This gives you a second bite of the apple when they exit in five to seven years.

To make this decision, run both offers through your V/TO®. Ask yourself which path aligns with your long-term personal and professional goals.

Evaluate the strategic offer by analyzing the earnout terms. If the earnout is tied to metrics you cannot control post-close because they are integrating your sales team, the higher strategic price is mostly an illusion.

Evaluate the financial sponsor offer by assessing their track record of scaling platforms. If they have a proven history of growing businesses and your Accountability Chart shows you have a capable leadership team ready to run day-to-day operations without you, the rollover equity could end up being worth multiple times its initial value. Choose the structure that matches your tolerance for post-close operational integration and your belief in the platform's future growth.